Table 2. Characteristics of HTGP Patients with TG < 2648 and TG ≥ 2648.
| TG < 2648 (n = 66) | TG ≥ 2648(n = 78) | χ2 or t | P value a | |
|---|---|---|---|---|
| Age, M±SE | 43.02±1.18 | 41.14±0.78 | 1.328 | 0.187 |
| Sex, n (%) | 0.415 | 0.520 | ||
| Female | 17(25.76) | 25(32.05) | ||
| Male | 49(74.24) | 53(67.95) | ||
| BMI, M±SE | 26.37±0.64 | 26.91±0.62 | 0.608 | 0.544 |
| DM (%) | 0.272 | 0.602 | ||
| Yes | 36(54.55) | 47(60.26) | ||
| HTN (%) | 1.465 | 0.226 | ||
| Yes | 24(36.36) | 20(25.64) | ||
| CAD (%) | 0.072 | 0.789 | ||
| Yes | 5(7.58) | 8(10.26) | ||
| Pulmonary disease (%) | 0.058 | 0.849 | ||
| Yes | 7(10.6) | 9(11.54) | ||
| CKD (%) | 0.226 | 0.637 | ||
| Yes | 6(9) | 10(12.82) | ||
| Lipase (U/L) | 730.61±117.90 | 932.34±121.28 | 1.193 | 0.235 |
| Amylase (U/L) | 260.97±43.71 | 268.63±38.31 | 0.131 | 0.896 |
| Na (mmol/L) | 132.05±0.47 | 129.92±0.50 | 3.048 | 0.003* |
| HCO3 (mEq/L) | 23.22±0.62 | 20.58±0.57 | 3.106 | 0.002* |
| Glucose (mg/dl) | 198.58±16.68 | 248.81±14.11 | 2.315 | 0.022* |
| Albumin (g/dL) | 3.68±0.06 | 3.73±0.07 | 0.574 | 0.567 |
| Total calcium (mg/dL) | 8.07±0.15 | 7.72±0.15 | 1.617 | 0.108 |
| Total cholesterol (mg/dL) | 294.44±14.61 | 393.61±27.85 | 3.153 | 0.002* |
| LDH (U/L) | 318.44±36.59 | 371.40±32.71 | 1.081 | 0.282 |
| Uric acid (mg/dL) | 5.61±0.30 | 5.89±0.24 | 0.738 | 0.462 |
| CRP (mg/dL) | 8.86±1.76 | 9.10±1.70 | 0.098 | 0.922 |
| BUN (mg/dL) | 14.78±1.17 | 22.73±3.56 | 2.122 | 0.037* |
BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; CAD, coronary artery disease; CKD, chronic kidney disease; LDH, lactate dehydrogenase; CRP, C-reactive protein; BUN, blood urea nitrogen; M ± SE, Mean ± standard error
aIndependent t-test or chi-square test.
* P < 0.05; Pulmonary disease was defined as a history of asthma or chronic obstructive pulmonary disease.